Bioactive supramolecular peptide nanofibers for regenerative medicine by Arslan, E. et al.
© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
www.advhealthmat.de
www.MaterialsViews.com
wileyonlinelibrary.com 1357
R
EV
IEW
 Bioactive Supramolecular Peptide Nanofi bers for 
Regenerative Medicine 
 Elif  Arslan ,  I. Ceren  Garip ,  Gulcihan  Gulseren ,  Ayse B.  Tekinay , *  and  Mustafa O.  Guler * 
 E. Arslan, I. C. Garip, G. Gulseren 
 Institute of Materials Science and Nanotechnology 
National Nanotechnology Research Center (UNAM) 
 Bilkent University 
 Ankara  06800,  Turkey 
 Prof. A. B. Tekinay, Prof. M. O. Guler 
 Institute of Materials Science and Nanotechnology 
National Nanotechnology Research Center (UNAM) 
 Bilkent University 
 Ankara  06800 ,  Turkey  
E-mail:  atekinay@unam.bilkent.edu.tr;  moguler@unam.bilkent.edu.tr 
DOI: 10.1002/adhm.201300491
many aspects of tissue regeneration. [ 1 ] 
Peptide nanofi bers are particularly advan-
tageous in this capacity, as they undergo 
a relatively simple self-assembly process, 
and can be designed to display desirable 
structural properties. While the biodeg-
radability, oxygen permeability and water 
storage capacity of hydrogels have led to 
their extensive clinical use since 1980s, 
such fi rst examples of hydrogels were 
bioinert and could not adequately satisfy 
the strict physiological demands inherent 
to all human tissues. This problem ren-
dered it necessary to develop biomimetic 
peptide networks capable of activating 
specifi c biological responses and coordi-
nating a wide variety of cellular processes 
such as cell spreading, differentiation, tissue repair, and regen-
eration ( Figure  1 ). In  Table  1 , the list of advantages and draw-
backs of peptide nanostructures is summarized. 
 To guide natural cellular activities, biomaterials should 
provide a microenvironment similar to that experienced by 
cells under natural conditions. The native extracellular matrix 
(ECM) both provides a suitable physical environment and 
incorporates the necessary set of biochemical and mechan-
ical signals to ensure the normal function of cells, as well as 
mediating their differentiation, morphogenesis, and homeo-
stasis. [ 2 ] Its composition is tissue-specifi c and heterogeneous, 
which can be exploited by biomimetic peptides to selectively 
trigger a particular biological activity, such as cell adhesion, 
spreading, growth, or differentiation for a specifi c subset of 
cells. Integration of a bioactive signal into a given biomate-
rial will result in the induction of specifi c cell surface recep-
tors, which can steer the cell population towards a desired 
behavior. In addition, when cells are in a synthetic environ-
ment, their response and eventual fate will be affected by the 
physical and chemical features of the biomaterial. In both 2D 
and 3D systems, hydrophobicity, charge, porosity, roughness, 
and the presence of micro- or nanostructures on the surface, 
as well as mechanical and physicochemical characteristics, 
must therefore be considered for bioactive material design. [ 3,4 ] 
In  Table  2 , the specifi c features of biomaterials used as scaf-
fold are summarized. 
 In niches generated by peptide molecules, the order in 
which epitopes are presented to cells, as well as their intensity, 
are signifi cant factors in directing cell behavior. [ 5 ] Usually, cells 
adhere to the surface of biomaterials through the adsorbed 
protein layer. [ 6 ] The properties of this protein layer, such as its 
concentration and distribution, also have fundamental roles of 
 Recent advances in understanding of cell–matrix interactions and the role of 
the extracellular matrix (ECM) in regulation of cellular behavior have cre-
ated new perspectives for regenerative medicine. Supramolecular peptide 
nanofi ber systems have been used as synthetic scaffolds in regenerative 
medicine applications due to their tailorable properties and ability to mimic 
ECM proteins. Through designed bioactive epitopes, peptide nanofi ber 
systems provide biomolecular recognition sites that can trigger specifi c 
interactions with cell surface receptors. The present Review covers structural 
and biochemical properties of the self-assembled peptide nanofi bers for 
tissue regeneration, and highlights studies that investigate the ability of ECM 
mimetic peptides to alter cellular behavior including cell adhesion, prolifera-
tion, and/or differentiation. 
 1.  Introduction 
 Developments in biomaterials science and materials chem-
istry enable de novo synthesis of bioactive molecules that 
self-assemble into hierarchical supramolecular structures, 
eliminating numerous issues associated with the generation 
of complex networks. With a deeper understanding of cell–
materials and cell–matrix interactions, materials scientists 
now possess the necessary toolkit to alter cellular processes via 
engineered biomaterials, which have become indispensable for 
numerous applications in regenerative medicine. Self-assem-
bled peptide nanofi bers comprise one of the major classes of 
such bioactive materials, and have received substantial atten-
tion in the recent decade. A particularly promising application 
of these peptide networks is the design of artifi cial extracellular 
matrices, which display the complex architecture and biochem-
ical properties of their natural counterparts and are crucial for 
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W regulating biological responses and functionality of the mate-rial. [ 7 ] Therefore, biomaterials capable of mimicking the natural 
niche and biochemical cues present in this interface can readily 
facilitate the attachment of cells. Peptide nanofi ber scaffolds 
engineered with porous structures and high surface to volume 
ratios provide a suitable spatiotemporal environment for cells 
to adhere on, and promote the material exchange between the 
scaffold and the environment. In addition, spatiotemporal sign-
aling patterns can be designed to favor the adhesion, prolif-
eration and/or differentiation of a selected population of cells. 
Cells continuously receive and process incoming information 
from the environment and remodel the extracellular structure 
by degrading it and depositing their own matrix components. 
This integrin-mediated dynamic and bidirectional interaction 
between cells and the environment are responsible for directing 
certain cellular processes to maintain tissue homeostasis. [ 8 ] 
 Understanding of specifi c cell–biomaterials and cell–ECM 
interactions is paramount to generate functional materials 
capable of inducing specifi c responses. Matrix proteins respon-
sible for organizing the cell microenvironment and regulating 
growth and differentiation are particularly promising candi-
dates for research and their receptor recognition sequences are 
frequently utilized to generate peptide nanostructures. Peptide 
chemistry offers a unique opportunity to engineer materials 
possessing these specifi c sequences and structures, which 
may lead to their practical application in regenerative medi-
cine. ECM protein mimics are extensively utilized to guide cell 
behavior in regenerative medicine, [ 26 ] effectively simplifying 
their models’ sophisticated structures without compromising 
their critical role in maintaining metabolic equilibrium in 
living systems. In this respect, supramolecular peptide nano-
fi bers have already demonstrated their potential to mimic 
native ECM with minimal complexity while retaining their 
desired chemical functions. Among the synthetic regenerative 
approaches, self-assembled peptide nanofi ber 
systems have a special importance due to 
their diversity of function and inherent com-
patibility with biological systems. In this 
Review, we summarize design and synthesis 
methods associated with peptide nanofi bers, 
and applications of this important synthetic 
biomaterials class in regenerative medicine. 
 2.  Design and Synthesis of Peptide 
Nanostructures 
 Solid-phase peptide synthesis facilitates 
production of various synthetic peptides. [ 27 ] 
Among synthetic peptide materials, hydro-
gels are notable for their exceptional struc-
tural and functional features. Monomers 
of synthetically prepared peptide hydrogels 
are generally classifi ed into mono, di-, and 
tripeptides, and peptide amphiphiles (PAs), 
which frequently display complex motifs 
such as α-helices, β-sheets, coiled-coils, 
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 Figure 1.  Schematic illustration of biomaterial properties and their possible impact on cell fate.
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β-hairpins, and triple helices. In addition, chemical modifi ca-
tion of basic peptide motifs can be utilized to provide advanced 
and additional functions to nanofi ber matrices. 
 2.1.  Self-Assembly Mechanisms 
 Amino acids such as phenylalanine and tyrosine are among the 
smallest hydrogelators studied. [ 28 ] Despite their small unit frag-
ments, single amino acid molecules are observed to be effi cient, 
pH dependent, and thermally reversible hydrogelators. Their 
small sizes, ease of preparation, and simple structures have 
made these protected amino acids preferable hydrogelators, 
and they have become attractive reagents for use in biomedical 
applications. Monopeptide variants are also frequently utilized 
for self-assembly, among which the Fmoc-protected amino 
acids are some of the most commonly studied versions. Fmoc 
amino acids have been utilized for a variety of other purposes, 
including external stimuli-triggered hydrogelation. Fmoc-Tyr 
phosphate provides one of the earliest examples of this phe-
nomenon, as the dephosphorylation of this modifi ed amino 
acid converts it into an effi cient hydrogelator. [ 29 ] Fmoc-protected 
amino acids form hydrogels through π–π interactions of the 
Fmoc groups and intermolecular antiparallel hydrogen bonding 
of the peptide bonds. [ 30 ] However, availability of more than 
20 standard and non-standard amino acids, with side chains 
bearing aromatic, hydrophobic, hydrophilic, acidic, and basic 
moieties, results in large variances of gelation behavior among 
Fmoc-monopeptides. For example, while Fmoc-Tyr undergoes 
spontaneous self-assembly in the presence of water, [ 31 ] the 
self-assembly of Fmoc-Phe requires a careful pH adjustment 
from basic to neutral acidic. [ 32 ] Beside various amino acid side 
chains, critical properties (gelation, functional activity, structure 
etc.) of peptide hydrogels can be altered not only via endoge-
nous design and but also by external factors such as pH, tem-
perature, and chemical modifi cation. Gelation capability in 
particular can be augmented with minor modifi cations. Pep-
tide self-assembly is strongly dependent on the presence of 
hydrophobic sites or side chains, and can be changed in the 
absence of a hydrophobic side chain. Electron defi ciency is an 
important parameter to increase the hydrophobicity of the side 
chain, and electron acceptors such as halogens can be incor-
porated into the side chain to enhance its hydrophobicity and 
therefore increase gelation effi ciency. Pentafl uorination of the 
phenylalanine side chain, for example, signifi cantly decreases 
the electron density on the phenyl ring, and the resulting elec-
tron defi ciency increases the hydrophobicity of the side chain. 
Substitution is another important factor, especially for aromatic 
π–π-induced self-assembly: The  ortho- substitution in particular 
attains an electronically favorable structural reorganization that 
enhances complementary π–π stacking. [ 33 ] 
 Similar to single amino acid derivatives, small molecule 
hydrogelators also display potential to serve as a general plat-
form for a wide range of applications. These structures are 
composed of more than one amino acid, potentially in conjunc-
tion with a variety of protective and supportive units. As previ-
ously mentioned, aromatic interactions play a signifi cant role 
during the self-assembly process, particularly for the formation 
of tubular structures. For example, the small molecule hydroge-
lator diphenylalanine peptide and its modifi ed analogues have 
been reported to form amyloid-like tubular fi bers as a result 
of their self-assembly process. [ 35 ] The hallmark feature of the 
diphenylalanine hydrogel is its remarkable mechanical rigidity, 
which exceeds those of hydrogels formed by longer polypep-
tides. [ 34 ] This type of hydrogel is resistant across a broad range 
of pH and temperature, and to the presence of some detergents. 
While self-assembly of this peptide is triggered by aromatic 
interactions and hydrogen bonds between amide groups, the 
extraordinary resistance of the hydrogel is principally caused by 
the directionality of gelation process, provided by π–π stacking 
of amino acid groups and their contribution to the free energy 
of formation. 
 2.2.  Morphology of the Peptide Aggregates 
 The secondary structural motifs are the simplest higher order 
assembly after small molecular hydrogelators. The β-sheet, 
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 Table 1.  The list of advantages and drawbacks of peptide-based structures. 
Advantages of PAs Refs. Disadvantages of PAs Refs.
Self-assembly, defi ned sequence design  [3,83,100,102] Mechanical weakness  [146] 
Bioactivity, biodegradability, oxygen-permeability, high water storage, 
high porosity, high surface-to-volume ratio
 [3,4,141,142] Low conductivity  [147,148] 
Open to modifi cations 
(based on several parameters such as pH and temperature)
 [143,144] Restricted number of building blocks and limited 
sequence size, limited control on fi nal structural size
 [142] 
Structural variability and well-defi ned shapes 
(e.g., nanofi ber, nanotube, nanoribbon, etc.)
 [81,149,150] Stability and solubility issues  [141,151] 
Mild synthesis conditions, low-cost, fast-synthesis  [141,144,145] 
 Table 2.  Properties of scaffolds affecting cell interactions. 
Physical and chemical features Refs.
Hydrophobicity  [9–11] 
Charge  [11,12] 
Porosity  [13,14] 
Roughness  [9,12] 
Presence of micro- and nanostructures  [15–17] 
Mechanical characteristics (elasticity, stiffness etc.)  [13,18–20] 
The order and intensity of the epitope  [21,22] 
Physicochemical characteristics  [23–25] 
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connected by backbone hydrogen bonds to create a pleated 
sheet. Fibrous β-sheet scaffolds are generally formed by 
mixing two-molar-equivalent solutions of oppositely charged 
peptides, however, acidic and amphiphilic β-sheet-forming 
peptides could also be utilized for β-sheet formation, even at 
pH values much higher than the intrinsic p K a of their amino 
acid side chains. Ionic strength and correlation between 
the hydrophobic parts and aromatic groups also play a role 
in β-sheet assembly. The effect of ionic strength on β-sheet 
formation has been investigated by using Ac-(XKXK) 2 -Am 
peptide, [ 36,37 ] where charged lysine side chain was utilized to 
obtain pH responsiveness. At low pH, peptides remained at 
monomeric stage due to the repulsion of positive charge on 
side chain. Lysine residues generated cross-β fi bril structure 
with the help of increasing solvent ionic strength as a result 
of shielded repulsive charge–charge interactions. Aromatic 
group attachments on the backbones of peptides also display 
signifi cant effect for self-assembly mechanism. [ 38 ] Signifi cance 
of aromatic group addition is the capability of these groups 
to lead nanotape and nanoribbon formation apart from non-
aromatic peptides. 
 The β-hairpin is another secondary structural form and con-
sists of two β-strands forming a hairpin shape. The β-hairpins 
are composed of two antiparallel β-strands joined by a loop and 
are commonly recognized components of proteins. Both inter-
molecular hydrogen bonding and association of hydrophobic 
faces are the main forces that drive the formation of unique 
folded conformation of individual hairpins. [ 39 ] Due to their 
high solubility, β-hairpin peptides also tend to form coiled coils. 
However, intermolecular folding initiated by external stimuli 
can induce β-sheet rich and highly cross-linked β-hairpin for-
mation. Like β-sheet formation process, β-hairpin folding and 
assembly occurs in response to changes in pH or ionic strength. 
Additionally, changes in heat, [ 39 ] light, or inclusion of cell cul-
ture media to buffered solutions of unfolded peptides result 
in rigid secondary structure formation. In one study, MAX1 [ 40 ] 
peptide showed pH-sensitive folding characteristics under basic 
conditions or in the presence of salt, and ionic-strength-driven 
β-hairpin monomers were induced to form hydrogel network. 
In further examples, the distinctive derivatives of MAX pep-
tides (MAX3), [ 39 ] showed folding responses against different 
stimuli including thermal trigger. 
 Coiled coils are secondary structural motifs constructed by 
two or more alpha-helices that associate with each other to 
form dimers, or more multimeric structures. Two, three, or 
four helices may be present in a single bundle, and these bun-
dles may orient in the same (parallel) or opposite (antiparallel) 
directions. Each strand of a coiled-coil peptide unit can be con-
sidered as a repeated coupling substring of the form a-b-c-d-e-f-
g sites, where a-b-c-d-e-f-g are the seven different constitutional 
positions on the coil. The fi rst and fourth position (a and d) are 
generally nonpolar or hydrophobic amino acids. When the two 
substrings coil around each other, positions a and d are inter-
nalized to stabilize the structure, while remaining positions 
are exposed on the peptide surface. Leucine-zipper, which has 
been proven to be important for protein function, [ 41 ] is one of 
the well-studied subtypes of coiled coil constructs, in which the 
amino acid leucine is predominant at the “d” position of the 
heptad repeat. These domains may be shorter than 28 amino 
acids. 
 Scientists and engineers have also explored the higher 
order self-assembly type called triple helical assembly. This 
helical formation has become a promising structural motif for 
engineering hierarchical and self-assembled constructs mim-
icking natural tissue scaffolds, which are expected to exhibit 
specifi c biological activities. [ 42 ] In nature, collagen is a well-
known multi-hierarchical structure that provides the building 
block for connective tissues. Triple helical peptides with Pro-
Hyp-Gly (POG) peptide units can be used to mimic the high-
level structure of collagen. [ 43 ] POG fragments undergo self-
triggered triple helix formation and these triple helices then 
pack against one another in a hexagonal and staggered fashion 
to form nanofi brous structures. Collagen fi bers proceed to 
self-assemble both linearly and laterally to establish collagen 
mimetic fi bers and a hydrogel network. Since the triple helix 
motif found in collagen is unique and highly specifi c, and 
it is a promising candidate of biomimetic strategy for tissue 
regeneration. 
 Self-assembling amphiphilic peptides also form various 
morphologies including fi bers, tubes, and vesicles. [ 44 ] These 
peptides contain hydrophobic and hydrophilic residues, which 
affect assembly of amino acid sequence into specifi c secondary 
structures [ 45 ] including β-sheets and α-helices. Multiple nonco-
valent interactions drive the spontaneous self-assembly of indi-
vidual PA molecules into supramolecular nanostructures under 
physiological conditions. [ 46 ] Such noncovalent interactions are 
coded in the sequence of PAs and include hydrogen bonding, 
van der Waals forces, Casimir effect, electrostatic associations, 
and hydrophobic interactions. Through these intermolecular 
interactions, especially β-sheet-forming peptides assemble into 
1D nanostructures, which can form 3D fi brous networks. The 
representative structure of PA molecules composed of one alkyl 
chain connecting with several amino acid sequences is shown 
in  Figure  2 . [ 46 ] 
 The hydrophobic alkyl group imitates the nonpolar “tail” 
region found in fatty acids. This hydrophobic segment can be 
modulated by using different chain lengths, components, and 
structures. For example, by using less twisted β-sheet struc-
tures, stiffer materials can be formed. [ 47 ] Charged residues can 
also be incorporated into this region to provide aqueous solu-
bility and regulate hydrogelation. [ 48 ] Bioactive domains can be 
composed of different peptide epitopes according to the pur-
pose of design such as phosphorylated serine, which interact 
with calcium ions for mineralization of hydroxyapatite (HA). [ 45 ] 
This domain presents the bioactivity feature of PAs through 
specially designed oligo-peptide sequences used as signals for 
cell adhesion, viability, proliferation, migration, and differentia-
tion. [ 49 ] These amphiphilic peptides can form fi brous networks, 
which are capable of mimicking the dynamic nature of tissue 
microenvironment. With this fi brous organization and proper 
composition, they can function cooperatively to achieve the 
required harmony of fl exibility, strength, structural integrity, 
and complexity of the native extracellular tissue. Due to their 
biocompatible and biodegradable nature, hydrogels formed by 
peptide nanofi bers have been used to study induction of repair 
of damaged tissues in regenerative medicine both in vitro and 
Adv. Healthcare Mater. 2014, 3, 1357–1376
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in vivo . There are several studies about self-assembled pep-
tide nanofi ber systems, [ 50–55 ] their characterizations, [ 56–59 ] and 
applications in regenerative medicine. [ 60–64 ] Design of bioactive 
peptide nanostructures depends on the application and tissue 
type. To induce desired cellular responses such as differentia-
tion and repair, various bioactive sequences can be incorporated 
into peptide nanostructures. [ 65 ] Another example is RADA pep-
tides, containing repeated hydrophilic and hydrophobic amino 
acid sequences (about 8–16 residues), which provide both polar 
and nonpolar features to the peptide. [ 66–70 ] Some of these bio-
active sequences, which were exploited in different biomedical 
studies, are shown in  Table  3 . 
 3.  Biomedical Applications of Peptide Nanofi bers 
 3.1.  Bone Regeneration and Biomineralization 
 Bone is a highly mineralized, metabolically active and vascular-
ized connective tissue and constitutes the major structural and 
supportive tissue in the body. Bone defects can occur as a result 
of trauma, tumors, biochemical disorders, abnormal skeletal 
development, and severe infections, all of which necessitate 
urgent medical attention and often require surgical interven-
tion for the reconstruction of the lost bone tissue. [ 94 ] However, 
osseointegration of the implant and the formation of new bone 
tissue must also occur for complete recovery. Bone formation 
is initiated with the recruitment and proliferation of osteopro-
genitor cells, which later differentiate into osteoblasts to facili-
tate the production of bone ECM and eventual mineralization 
of the tissue. [ 95 ] 
 Scaffolds for bone regeneration and biomineralization are 
expected to meet rigid requirements in mechanical tolerance, 
biocompatibility, and biodegradability. [ 96 ] In bone regeneration 
strategies, an important consideration is the wide diversity of 
problems associated with this tissue and its unique combina-
tion of mechanical, structural, and biological properties. While 
a large variety of materials have been utilized to overcome 
such issues, inert and mechanically supportive metals and 
alloys have so far been widely used as bone implants. However, 
despite the success of metallic implants and surface modifi ca-
tion techniques currently used to accelerate the bone healing 
process, such surfaces are largely incapable of attracting 
osteogenic cells in the initial step of osseointegration. Bio-
chemical modifi cations, such as incorporation of growth fac-
tors or ECM proteins to implant surfaces, are therefore critical 
to induce adequate cell attachment and differentiation during 
bone repair, especially in conjunction with the optimization 
of surface roughness and topography. Even though ECM pro-
teins found in bone matrix, such as collagen and fi bronectin, 
are large macromolecules, their integrin recognition parts are 
short peptide sequences and it is their interaction with inte-
grins and other surface receptors that triggers critical down-
stream processes such as adhesion and signaling. Thus, PAs 
with short bioactive peptide sequences have great potential as 
scaffolds to induce bone tissue growth and biomineralization. 
Peptides and protein fragments containing RGD, an adhe-
sive sequence found in fi bronectin, vitronectin, bone sialo-
protein, and osteopontin, [ 97 ] were initially used to mimic the 
function of these proteins. [ 98 ] In one of the earlier examples, 
a supramolecular platform containing a bioactive epitope 
was designed to trigger the mineralization process. [ 99 ] In this 
Adv. Healthcare Mater. 2014, 3, 1357–1376
 Figure 2.  A-I) A hydrophobic alkyl tail, A-II) β-sheet forming segment, A-III) One or more charged amino acids providing aqueous solubility and 
further regulate gelation, A-IV) A bioactive epitope. B) Representation of a self-assembled PA nanofi ber. C) TEM image of PA nanofi bers in aqueous 
environment. D) SEM image of a PA gel in cell culture media. E) Image of the PA gel formed. Reproduced with permission. [ 48 ] Copyright 2002, Elsevier.
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system, the phosphoserine residue, which is characteristic of 
proteins found in mineralized tissues, was utilized to elicit the 
deposition of HA, and it has been shown that the pH-induced, 
self-assembled, phosphoserine-bearing PA matrix was a useful 
template for the formation of HA crystals. [ 100 ] Another study 
focused on the effect of PAs on tooth regeneration, using a 3D 
nanofi ber scaffold formed by PAs bearing RGD epitopes. [ 101 ] 
Ameloblast-like cells (line LS8) and primary enamel organ epi-
thelial (EOE) cells were cultured on the biomimetic scaffold, 
and showed enhanced proliferation and expression of amelo-
genin, an important protein in the development of enamel. [ 101 ] 
In the in vivo part of this study, the RGD-PA hydrogel was 
Carbon monoxide-releasing PA Ru (CO) 3 Clr (glycinate) motif similar to CORM-3 
(spontaneously releases CO)
Prolong CO release, and localized therapeutic CO 
delivery for oxidatively stressed cardiomyocytes
 [92] 
RADA (Ac-RADARADARADARADA-Am) Originally designed as ionic self-complementary oligo-
peptides, resembling RGD motif
Cell adhesion neurite outgrowth and neuron 
differentiation
 [68,93] 
Adv. Healthcare Mater. 2014, 3, 1357–1376
 Table 3.  Peptide sequences, their origin and their bioactivity role in tissue regeneration. 
Peptide sequence and bioactive peptide 
nanofi bers
Origin Bioactivity role Refs.
RGDS In many ECM proteins, Integrin binding epitope—found 
mostly in fi bronectin and also ameloblastin (Ambn),
 Cell adhesion 
 Enamel regeneration: cell adhesion to the enamel ECM 
 [71–73] 
IKVAV Laminin Cell adhesion, spreading, migration, and neurite 
outgrowth
 [74,75] 
YIGSR Laminin Multimeric form inhibits angiogenesis, tumor growth 
and experimental metastasis more than the monomeric 
form
 [76,77] 
Aligned PA nanofi bers Forming monodomain gel Directional guidance for regenerating axons  [78] 
Heparin Binding Peptide amphiphile Specifi cally bind heparan sulphate-like glycosaminogly-
cans (HSGAG)
Binds various signaling proteins through their heparin-
binding domains; such as fi broblast growth factor 2 
(FGF-2), bone morphogenetic protein 2 (BMP-2) and 
vascular endothelial growth factor (VEGF)
 [138] 
PHSRN A sequence that binds synergistically with RGD, is 
located on an adjacent region of FN and is close enough 
to be recognized by the same integrin
Cell adhesion  [80,139] 
GFOGER and GAOGER Sequences in Col-IV Collagen mimetic  [79,82] 
Cationic α-helical (KLAKLAK) 2 Cationic peptides not internalized through cell 
membrane
Induce cancer cell death by membrane disruption  [140] 
TGF-β binding PA (HSNGLPL) Phage display to fi nd a peptide sequence (HSNGLPL) 
with a binding affi nity to transforming growth factor β1 
(TGF-β1)
Articular cartilage regeneration  [85] 
LRAP Naturally occuring amelogenin splicing isoform, 
leucine-rich amelogenin peptide (LRAP), induction of 
osteogenesis in various cell types
LRAP activates the canonical Wnt signaling pathway 
to induce osteogenic differentiation of mouse ES cells 
through the concerted regulation of Wnt agonists and 
antagonists
 [86] 
VEGF PA VEGF-(vascular endothelial growth factor) angiogenic 
factor a mitogen specifi c for endothelial cells
Recognition of VEGF receptors for induction of endothe-
lial cell proliferation and angiogenesis
 [65] 
Peptide nucleic acid/peptide amphiphile 
conjugate (PNA-PA)
Uncharged PNA backbone providing thermally strong 
PNA−DNA and PNA−RNA duplexes and triplexes
Binds to oligonucleotides with high affi nity and speci-
fi city after self-assembly into nanostructures.
 [87] 
E 3 PA(palmitoyl-A4 G3E3) Self-assemble into high aspect ratio cylindrical 
nanofi bers and encapsulation of drugs by hydrophobic 
collapse
Antitumor drug encapsulation  [88] 
GAG-PA heparan-sulfate-mimicking PA 
(HSM-PA)
Heparan sulfate interacts with many ECM molecules 
and growth factors
Promoting neurite outgrowth, promote angiogenesis 
without the need for addition of exogenous heparin or 
growth factors
 [89] 
KRSR Binds to transmembrane proteoglycans Selectively increase osteoblast adhesion when function-
alized with other bio-adhesive moieties
 [84,90] 
DGEA Collagen type I adhesive peptide sequence Specifi c binding for osteoblasts via alpha2-beta1 integrin  [84] 
YIGSR-IKVAV hybrid form Laminin Supporting neuronal survival and morphogenesis  [76] 
Dexamethasone-releasing PA Providing covalent attachment via a hydrazone and 
controlling drug release
Controlled drug release  [91] 
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injected to mouse incisors and found to encourage the prolif-
eration of EOE cells in the site of injection, as well as their 
differentiation to ameloblasts, suggesting that RGD-PA nano-
fi bers might be able to participate in integrin-mediated cell–
matrix adhesion interactions and to introduce the necessary 
signals for enamel formation. 
 Peptide amphiphile nanofi bers are also used to function-
alize implant materials to be used as bone plates, stents, and 
artifi cial joints. [ 5,102,103 ] For this purpose, the cellular adhesion 
sequence RGDS was used to covalently functionalize NiTi 
surfaces, and the bioactivity of the PA system was evaluated 
in terms of cellular adhesion and proliferation of osteoblasts 
and endothelial cells. [ 104 ] These PA nanofi bers were shown 
to facilitate cell adhesion and enhance the proliferation of 
cells within 7 d. The ability of the self-assembled peptide 
nanostructured hydrogels to promote bone regeneration was 
investigated in another study, where the phospho-serine-
containing peptide (S(P)-PA), and the RGD epitope-bearing 
peptide (RGDS-PA) were tested in a rat femoral critical-size 
defect model, and were shown to support bone regenera-
tion in 4 weeks by histology analysis and micro-computed 
tomography. [ 105 ] 
 The GFOGER peptide sequence is another important signal, 
which was derived from collagen and is known to bind inte-
grin α2β1, a key protein in osteogenesis. Recognition of this 
sequence occurs in a conformation-dependent manner, which 
is unusual for collagen-derived sequences. [ 106 ] This signal 
sequence has been used to induce osteoprogenitor cells to dif-
ferentiate into osteoblasts, and Wojtowicz et al. have shown that 
polycaprolactone scaffolds coated with GFOGER promote bone 
formation in critical-sized segmental defects in rats. In par-
ticular, passively adsorbed GFOGER coatings signifi cantly accel-
erated and increased bone formation in non-healing femoral 
defects compared to uncoated scaffolds and empty defects. [ 82 ] 
Three-dimensional micro-CT reconstruction images also 
demonstrated that defects treated with GFOGER-coated scaf-
folds were almost entirely repaired after 12 weeks ( Figure  3 ). 
 Collagen I is another important component of the bone 
ECM, and bioactive sequences derived from this protein are 
prime candidates for induction of bone tissue regeneration. 
DGEA, a signal sequence derived from the α1 helix of col-
lagen I, has been investigated for its osteoinductive poten-
tial, and DGEA-coated HA disks were found to upregulate 
the differentiation of mesenchymal stem cells into osteo-
blasts. [ 107 ] However, another study has reported a lack of 
adhesion by rat calvarial osteoblasts onto a CGGDGEAG 
sequence. [ 108 ] 
 Anderson et al. investigated the osteoinductive potentials 
of DGEA-PA, RGDS-PA, and S-PA in combination with a 
conditional medium. Histochemical staining and PCR results 
showed that the RGDS- and DGEA-PA functionalized surfaces 
enhanced osteogenic differentiation, compared with S-PA-
coated and TCP control surfaces. [ 109 ] 
 The KRSR peptide, found in heparin-binding proteins of the 
ECM, promotes selective adhesion of osteoblasts while inhib-
iting the adhesion of fi broblasts. [ 95,110 ] Previously, titanium 
alloy (Ti6Al4V) surface was functionalized with KRSR-PA and 
DOPA-conjugated PA, and combination of these two biomimetic 
sequences induced osteogenic differentiation. [ 103 ] Immobiliza-
tion of bioactive nanofi bers onto Ti6Al4V was mediated by Dopa-
PA ( Figure  4 ) and the osteoconductive interface led to the induc-
tion of osteogenesis of osteoblast-like cells (Saos2 cells), which 
and inhibition of fi broblast adhesion and viability. [ 103 ] Alkaline 
phosphatase activity assay and Alizarin Red S staining results 
clearly demonstrated osteogenic differentiation of Saos2 cells 
( Figure  5 ). 
 Bone morphogenetic protein-2 (BMP-2) is an important 
factor regulating bone differentiation. Lee et al. generated an 
osteopromotive nanofi ber network incorporating BMP receptor-
binding sequences and calcium ions. [ 111 ] Calcein staining and 
Adv. Healthcare Mater. 2014, 3, 1357–1376
 Figure 3.  A) Three-dimensional micro-CT representative images of GFOGER-coated scaffolds after 12 weeks. Reproduced with permission. [ 82 ] Copy-
right 2010, Elsevier. B) Structure of a collagen mimetic peptide with the bioactive epitope GFOGER. Reproduced with permission. [ 106 ] Copyright 2011, 
American Chemical Society.
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ALP activity measurements demonstrated that human bone 
marrow stromal cells (hBMSCs) grown on BMP-mimetic 
hydrogels displayed osteogenic differentiation. It was also 
reported that self-assembled BMP receptor-binding peptides 
(termed osteopromotive domains, OPD) with DWIVA and 
A 4 G 3 EDWIVA sequences were capable of maintaining osteo-
genic activity ( Figure  6 ). 
 Recently, bone regeneration was examined through 
BMP-2 signaling with heparin-binding fi bronectin-like PA 
nanofi bers. [ 112 ] BMP-2, heparan sulfate, and fi bronectin fi bers 
were all able to interact within the matrix, as all three molecules 
could infi ltrate within the pores of a collagen scaffold. This 
combination was hypothesized to recreate the 3D confi gura-
tion of receptor–ligand interactions due to the synergistic effect 
of heparan sulfate-BMP-2 and heparan sulfate–fi bronectin 
interactions on receptor-ligand binding ( Figure  7 ). The ability 
of this complex matrix to induce bone regeneration was dem-
onstrated on a rat femoral critical-size defect model, where 
less than 10% of the required dose of BMP-2 was suffi cient to 
repair the tissue damage when the biomimetic supramolecular 
system was used within the conventional collagen matrix 
( Figure  8 ). 
Adv. Healthcare Mater. 2014, 3, 1357–1376
 Figure 4.  Schematic illustration of immobilization strategy on titanium surface based on the self-assembly of the KRSR-PA and Dopa-PA. Reproduced 
with permission. [ 103 ] Copyright 2012, Royal Society of Chemistry.
 Figure 5.  A) ALP activity of Saos2 cells on functionalized surfaces. B ) Relative calcium deposition on the matrix. Reproduced with permission. [ 103 ] 
Copyright 2012, The Royal Society of Chemistry.
www.MaterialsViews.com
1365
www.advhealthmat.de
© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim wileyonlinelibrary.com
R
EV
IEW
 3.2.  Neural Tissue Regeneration with Peptide Nanofi bers 
 Inhibition of axonal regeneration and the inability of damaged 
neurons to form new functional connections are the main 
problems associated with nervous system repair. Functional 
recovery after injury and repair depends on a multitude of 
intrinsic and extrinsic factors, including neurotrophins, 
neuropoietic cytokines, insulin-like growth factors (IGFs), 
and glial cell-line-derived neurotrophic factors (GDNFs). [ 113 ] 
While advanced microsurgery techniques may result in an 
improved outcome, functional recovery is nonetheless poor 
due to the occurrence of motor and sensory defi cits. [ 114 ] Poor 
Adv. Healthcare Mater. 2014, 3, 1357–1376
 Figure 6.  Confocal images of the calcein-stained hBMSCs cultured on either a self-assembled OPDA network or a control PA gel. Reproduced with 
permission. [ 111 ] Copyright 2009, Elsevier.
 Figure 7.  A) Representative illustration of extracellular matrix components involved in ligand–receptor interactions through BMP-2 signaling. B) Rep-
resentative illustration of fi bronectin mimetic nanofi ber displaying sulfated polysaccharide strands on its surface, which can localize BMP-2 to facilitate 
receptor–ligand interactions. Reproduced with permission. [ 112 ] Copyright 2013, Elsevier.
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regenerative capacity was previously reported to be associated 
with the existence of anti-growth and anti-adhesion signals in 
the neural ECM, [ 68 ] suggesting that the negation of inhibitory 
signals may result in repair and regeneration of neural tissue, 
especially if inducers of proliferation and regeneration are 
also present at the damage site. [ 115 ] Therefore, generation of a 
mechanically and chemically suitable environment by means 
of a biomimetic scaffold may prevent the growth of scar tissue 
while promoting neuronal outgrowth. Bioactive self-assembled 
peptide scaffolds with cell-specifi c signals are promising tools 
for generating functional microenvironments for neural regen-
eration, and several studies have already been conducted on 
the applications of self-assembled peptide nanofi bers in neural 
tissue repair and regeneration. Holmes et al. used RADA16-I as 
a scaffold to enhance the neural differentiation of PC12 cells, 
and reported extensive primary neuron neurite outgrowth in 
the presence this peptide. In addition, they observed a “per-
missive” substrate effect of the peptide scaffold for primary 
neuronal synapse formation in vitro. [ 68 ] Another work utilized a 
3D network of PAs containing IKVAV peptide sequence, which 
was derived from the vital ECM component and neurite growth 
inducer, laminin. These nanofi bers assembled into hydro-
gels in aqueous environment and were found to facilitate the 
rapid differentiation of murine neuronal progenitor cells into 
neurons (NPC). IKVAV containing peptide nanofi bers could 
also inhibit astrocyte differentiation, which is likely to hinder 
glial scar formation and promote neural regeneration. Another 
important conclusion was that the ability of these peptides to 
induce selective and rapid differentiation of progenitor cells 
depended on the density of the bioactive epitope present in 
the nanofi bers. [ 116 ] In a 3D encapsulation study, Gelain et al. 
designed a self-assembled peptide nanofi ber (RADA16) func-
tionalized with a variety of motifs known to play roles in neural 
adhesion and differentiation. These motifs were based on RGD 
(RGDS from fi bronectin and PRGDSGYRGDS from collagen 
VI, both for neuron sprouting), laminin (YIGSR, IKVAV, and 
PDSGR, for neurite outgrowth in vitro and in 
vivo), a bioregulatory mediator domain from 
a myelopeptide (GFLGPT, for bone marrow 
and peripheral blood cell differentiation) 
and bone marrow homing peptides (SKP-
PGTSS (BMHP1) and PFSSTKT (BMHP2), 
for cell survival and cell differentiation). 
Gene expression analyses of genes, which are 
important in neural tissue formation, such 
as fubilin-1, demonstrated that the bioac-
tive motifs were signifi cantly more capable 
inducers of differentiation of neural cells 
compared with the Matrigel ( Figure  9 ). [ 71 ] 
 Peptide scaffolds were also effective in 
mitigating neural damage, as their presence 
enhanced the recovery of disrupted tissue and 
decreased the sequela. In this way, Ellis-Behnke 
et al. described a permissive microenviron-
ment formed by self-assembled peptide scaf-
folds (RADA16-I) for in vivo neural regenera-
tion. Their peptides could provide signifi cant 
axonal growth, facilitating the partial recovery 
of the optic tract and restoring functional 
vision in adult animals following a branchium 
Adv. Healthcare Mater. 2014, 3, 1357–1376
 Figure 8.  Micro-computed tomography results of femur reconstructions for various treatment groups. HBPA: Heparin Binding PA, HS: Heparan 
Sulfate. Reproduced with permission. [ 112 ] Copyright 2013, Elsevier.
 Figure 9.  Gene expression levels of the cells cultured on different peptide scaffolds. Adamts 
2–5: disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motif, 
2 or 5; Col3a1: Procollagen, type III, alpha 1; Col4a3: Procollagen, type IV, alpha 3; Col5a1: 
Procollagen, type V, alpha 1; Col5a1: Procollagen, type V, alpha 1; Emilin1: Elastin microfi bril 
interfacer 1; Fbln1: Fibulin 1; Lamb2: Laminin, beta 2; Ncam2: Neural cell adhesion molecule 
2; Spock1: Sparc/osteonectin, cwcv and kazal-like domains; Tnc: Tenascin C. Reproduced with 
permission. [ 71 ] Copyright 2006, PLOS.
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transaction. [ 117 ] In another study, IKVAV-containing peptide 
nanofi bers were shown to augment motor axon and sensory axon 
regeneration after spinal cord injury in vivo ( Figure  10 ). [ 75 ] 
 Zou et al. designed another peptide nanofi ber system, RADA-
FGL, by incorporating the FGL motif (EVYVVAENQQGKSKA, 
originally from Neural Cell Adhesion Molecule) into the peptide 
RADA16. Their peptide system was shown to be biocompatible, 
and displayed a permissive effect on neurite sprouting in rat 
dorsal ganglion neurons. [ 118 ] Zou et al. also designed self-assem-
bled nanostructures comprising functionalized peptides with 
four, two, or no glycine-spacers between the RADA16-I sequence 
and a motif (PESSTKT) from BMHP1. They demonstrated that 
the presence and length of glycine spacer signifi cantly alters 
functionality, and proposed that longer glycine spacers increase 
the effectiveness of the peptide sequence and enhance the via-
bility and differentiation of neural stem cells in vitro. [ 119 ] 
 In addition to regeneration of the central nervous system, 
neural tissue engineering has also focused extensively on sup-
porting the recovery of peripheral nervous system following 
an injury. Peptide nanofi bers are also promising scaffolds for 
such applications, and have been investigated by Angeloni 
et al. in their capacity as in vivo protein delivery vehicles. In 
their study, aligned PA gels incorporating the sonic hedgehog 
protein (SHH) have been utilized for regeneration of the 
cavernous nerve (CN), which enervates penis. SHH plays 
an important role in maintaining the structural integrity of 
the CN, as well as facilitating its regeneration after damage. 
Aligned PA nanofi bers ( Figure  11 ) can ideally present SHH, 
which is an essential protein, while providing directional guid-
ance to regenerating axons. SHH–PA fi bers placed on the 
CN were found to be capable of maintaining the integrity of 
myelinated fi bers and facilitating the development of axonal 
sprouts after 4 weeks, though the complete regeneration of 
the CN requires a longer period of time. Both qualitative and 
quantitative results suggested that SHH delivery with aligned 
PAs had a great potential for the CN regeneration ( Figure  12 ). 
Moreover, PA bundle treatment suppressed penile apoptosis 
and yielded a 58% improvement in erectile function in a 
shorter time period. [ 78 ] 
 In a recent study, Sur et al. described a hybrid matrix com-
posed of neuro-active PA and collagen. Combining the ben-
efi cial mechanical properties of collagen and the bioactivity of 
laminin-derived PA (IKVAV-PA and YIGSR-PA), their system 
could easily be adjusted to present different epitope densities, 
and displayed a benefi cial effect on neuronal viability and mor-
phogenesis ( Figure  13 ). [ 76 ] 
 A peptide nanofi ber system composed of heparan sul-
fate mimetic and laminin-derived epitopes was previously 
designed. The two bioactive components were presented on 
the nanofi ber scaffold, providing neural ECM analogues that 
Adv. Healthcare Mater. 2014, 3, 1357–1376
 Figure 10.  Enhancement in the regeneration of sensory axons within IKVAV PA. a,b) Neurolucida tracings of BDA-labeled descending motor fi bers a)
Vehicle-injected animals and b) IKVAV PA-injected animals. The dotted lines mark the borders of the lesion. c–f) Bright-fi eld images of BDA-labeled 
tracts c,e) in lesion and d,f) caudal to lesion used for Neurolucida tracings in an IKVAV PA-injected spinal cord (a,b). g,h) Graphics show the amount 
of labeled corticospinal axon penetration into the lesion. R, Rostral; C, caudal; D, dorsal; V, ventral. Scale bars: a–d) 100 µm; e–f) 25 µm. Reproduced 
with permission. [ 75 ] Copyright 2008, Society for Neuroscience.
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imitate the interaction of laminin with heparin sulphate pro-
teoglycan (HSPG). [ 120 ] Mammadov et al. demonstrated that 
the combination in question could cooperatively induce 
neurite outgrowth of PC-12 cells when compared with 
laminin-derived scaffold alone. In addition, this system was 
shown to be effective in bypassing the inhibitory action of CSPGs 
(chondroitin sulphate proteoglycans) on axonal growth 
( Figure  14 ). 
Adv. Healthcare Mater. 2014, 3, 1357–1376
 Figure 11.  a) Molecular structure of the Palmitoyl-VVAAEE-Am) PA; b) Representative image of the PA molecule, c) Self-assembly of PA molecules 
forming nanofi ber, d) Representative image of nanofi ber bundles. Reproduced with permission. [ 78 ] Copyright 2011, Elsevier.
 Figure 12.  a) Linear PA formation and in vivo application of PA b) Bilateral CN crush in EM of Sprague-Dawley rats: treated with BSA-PA (control) 
or SHH-PA for 4 weeks. Intact myelinated fi bers in the SHH treated CN and visible axonal sprouts in non-myelinated fi bers (asterisk). 30 000× and 
44 000×. Reproduced with permission. [ 78 ] Copyright 2011, Elsevier.
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 Figure 13.  Results of matrix composition on Purkinje cell (PC) morphology. A) Simulated fl uorescence process images of PCs (Calbindin , green), 
cultured on either collagen (upper, side view) or collagen/IKVAV–PA hybrid matrix (middle, side view; lower, bottom view). The arrowhead indicates 
the random short invasion of PC dendrite into the collagen substrate. Dendrite dispersal of non-PC cerebellar neurons is shown in red (Scale-10 µm) 
(MAP2.). B) Image pairs show the top view and side view of representative PC morphologies seen on hybrid matrices (Scale 20 µm). C) Plot of pro-
jected area and convex hull of PC surface dendrites against IKVAV–PA concentration. D) Plot of the PC vertical spans against different PA concentra-
tions. E) Morphologies of PC axon terminals for different PA concentrations (Scale 20 µm). Reproduced with permission. [ 76 ] Copyright 2012, Elsevier.
 Figure 14.  Optical microscope images of PC-12 cells bypass CSPG inhibition when cultured on PA scaffolds. Inhibition of neurite outgrowth of PC-12 
cells on a) collagen alone surfaces b) CSPG mixed collagen coated surfaces. Successful extension of neurites on both d) CSPG added and c) CSPG 
IKVAV-PA/HSM-PA scaffolds. Reproduced with permission. [ 120 ] Copyright 2012, Elsevier.
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 3.3.  Cartilage Regeneration with Peptide Nanofi bers 
 Despite rapid advances in other aspects of tissue engineering, 
the regeneration of damaged cartilage tissue remains as a 
challenge. Cartilage tissue engineering is primarily constrained 
by the low natural regenerative capacity of this tissue, which 
stems from its aneural, avascular, and alymphatic nature, as 
well as its limited cell supplies. As such, a great majority of the 
scaffolds designed for cartilage regeneration have been dissat-
isfactory, and mimicking natural ECM is now one of the cru-
cial goals of cartilage tissue engineering in order to eliminate 
the limitations imposed by the present issues. As self-assem-
bled PAs are strong ECM-mimetic material candidates, much 
research has been performed regarding their potential use in 
cartilage regeneration. In one such study, the peptide KLD-12 
(AcN-KLDLKLDLKLDL-NH 2 ) was used as a self-assembled pep-
tide hydrogel for encapsulation of chondrocytes in a 3D envi-
ronment, and was demonstrated to be comparable to other 
cartilage ECM-derived scaffolds for the retention of chondro-
cyte morphology. [ 69 ] In another study, the same peptide (KLD-
12) was also reported to promote the chondrogenesis of bone 
marrow-derived mesenchymal stem cells (BMSCs). As clearly 
demonstrated in AFM images, hydrogel-encapsulated BMSCs 
expressed aggrecans (one of the important cartilage ECM com-
pounds) with visibly larger average core-protein lengths than 
chondrocytes ( Figure  15 ). [ 121 ] 
 The effect of PA nanofi bers bound to a growth factor 
(TGF β1) on the chondrogenic differentiation of BMSCs was 
investigated, and it was demonstrated that this scaffold could 
induce cell proliferation, differentiation, and the production of 
cartilage-like ECM. [ 122 ] Shah et al. reported a PA bearing a high 
density of a transforming growth factor β-1(TGFβ-1) epitope 
and demonstrated its ability to enhance the viability and dif-
ferentiation of MSCs to chondrocytes in vitro, as well as sup-
porting regeneration of hyaline-like cartilage tissue in vivo. [ 85 ] 
Liu et al. have utilized a complex of a coalesced polymer, 
polyethylene glycol, and a collagen mimetic PA bearing the 
GFOGER sequence fl anked by GPO repeats. Their results sug-
gest that the integrated system in question contributed signifi -
cantly to the differentiation of hMSCs (human mesenchymal 
stem cells) into chondrocytes and augmented cartilage specifi c 
ECM production, in stark contrast to the polymer itself. [ 123 ] 
Recently, we also showed that glycosaminoglycan (GAG) 
mimetic PAs are highly promising for inducing chondrogen-
esis in vitro. [ 124 ] In particular, we have demonstrated that the 
cooperative effects of different molecules present in the natural 
ECM of chondrocytes may greatly assist in chondrogenic dif-
ferentiation ( Figure  16 ). 
 3.4.  Angiogenesis 
 Angiogenesis is the process of new blood vessel generation and 
plays an important role for normal functioning of tissues. [ 125 ] 
A fi ne balance between angiogenesis inducing and inhibiting 
factors regulates this process under normal conditions. This 
Adv. Healthcare Mater. 2014, 3, 1357–1376
 Figure 15.  AFM images of aggrecan molecules of G–I) adult chondrocytes and J–L) BMSC. The arrows indicate the ends of full length aggrecan mol-
ecules. Reproduced with permission. [ 121 ] Copyright 2010, Elsevier.
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balance, however, is compromised in pathological conditions, 
creating fl uctuations in blood vessel formation rates. As the 
regeneration of many tissues depends on the availability of 
healthy blood vessels, angiogenesis is also important in the 
process of wound healing, which renders it a crucial process in 
regenerative medicine. 
 Vascular endothelial growth factor (VEGF) is a major regu-
lator of angiogenesis, and its effects are mediated by receptor 
tyrosine kinases VEGFR1 and VEGFR2. In addition, many 
other molecules, such as FGF, bFGF, HGF, angiogenin, trans-
forming growth factor (TGF)-α, TGF-β, and tumor necrosis 
factor-α, are implicated to have roles in angiogenesis. [ 126 ] 
Proper functioning of these growth factors is moderated by 
binding to ECM glycosaminoglycans: HSPGs bind to growth 
factors and regulate the signaling pathways that promote or 
inhibit angiogenesis. [ 127,128 ] 
 Malkar et al. have reported the effect of PA mixtures 
on endothelial cell behavior, using fi lms of the angiogen-
esis-inducing sequence SPARC (secreted protein, acidic, 
cysteine-rich). SPARC-PA was found to promote cell adhe-
sion and spreading to a greater extent when combined with 
C 10 –[α1 (I)496–507], an integrin binding PA, and C 10 carbon 
chain, than it was alone. [ 129 ] In another study, angiogenic effect 
of heparin-binding peptide amphiphile (HBPA) hydrogels were 
evaluated in rat cornea. These nanostructures were found to 
promote maximal neovascularization response when combined 
with growth factors, compared to collagen gels with or without 
growth factors. [ 130 ] 
 In vivo reaction to HBPA nanofi ber gel networks and the 
effect of heparin on this reaction was examined by Ghanaati 
et al. A heparin-binding PA and a fl uorescein-conjugated PA 
were implanted subcutaneously to female CD-1 mice. Both 
static and dynamic analyses were performed to evaluate the 
in vivo biocompatibility of this angiogenic peptide, which was 
found to be excellent: The gels could persist in the tissue for 
up to 30 d, and de novo vascularized connective tissue was 
observed following their biodegradation. [ 131 ] 
 Since VEGF is an important stimulator of angiogenesis, PA 
nanostructures were also designed to display a sequence that 
imitates VEGF for ischemic tissue repair. [ 65 ] The sequence in 
question was KLTWQELYQLKYKGI-NH 2 and it was shown 
to specifi cally activate VEGF receptors in vitro, in addition 
to inducing angiogenesis in vivo. Angiogenic activity of this 
peptide was examined by chicken chorioallantoic membrane 
(CAM) assay, and the density of blood vessels was shown to 
increase signifi cantly upon exposure to VEGF–PA ( Figure  17 ). 
 A heparin-mimetic self-assembled PAs were investigated to 
induce angiogenesis in the absence of exogenous growth fac-
tors, and its in vivo effi cacy was evaluated. [ 89 ] In this study, the 
sulfonate group itself was not suffi cient for optimal angiogenic 
outcome, and other chemical groups were required to induce 
the formation of capillary-like structures by endothelial cells. 
The heparin mimetic peptide was able to fulfi ll this function by 
presenting critical functional groups of heparin and regulating 
growth factor signaling, without requiring any other angiogenic 
supplement ( Figure  18 ). Furthermore, heparin-mimetic PA gels 
 Figure 16.  a) Cell adhesion and j) cell viability bar graphs. b–i) Cellular response to peptide amphiphiles shown with confocal and EM imagings. 
Reproduced with permission. [ 124 ] Copyright 2013, American Chemical Society.
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supplemented with a combination of VEGF and FGF-2 could 
induce neovascularization in rat cornea more effi ciently com-
pared to growth factor solution alone. 
 3.5.  Cardiovascular Regeneration 
 Cardiovascular diseases are a major cause of death worldwide. 
Myocardial infarction, congestive heart failure, stroke, and 
other vascular diseases overall are respon-
sible for ≈30% of all deaths. [ 132 ] Cardiovas-
cular diseases affect not only human health 
but also the economic stability around the 
world, as those disorders cause the affected 
individual leave the active workforce. [ 133 ] 
Tissue engineering and regenerative medi-
cine can offer faster recovery, and thus lessen 
the socioeconomic burden among patients 
suffering from cardiovascular diseases. [ 133 ] 
Synthetic microenvironments resembling 
natural 3D structure of myocardial tissue 
is one of the crucial anticipation of car-
diovascular tissue engineering. The use of 
self-assembled peptide nanofi bers is a prom-
ising tool for cardiovascular regeneration as 
well. Davis et al. designed injectable peptide 
nanofi bers (RADA16-II) for the assembly of 
intramyocardial cellular microenvironments 
and showed enhanced neovascularization 
through endothelial cell invasion to peptide 
microenvironment. Moreover, when they 
introduced smooth muscle cells into peptide 
microenvironment, they observed that they 
assembled arterioles. In this comprehensive 
research, Davis et al. also showed the pres-
ence myocyte progenitor cell population in 
the peptide microenvironment. Their results 
also demonstrated the superior benefi t of 
self-assembled peptide nanofi bers over 
Matrigel. In addition, they showed the spon-
taneous differentiation of embryonic stem 
cells into cardiac myocytes inside peptide 
microenvironment in vivo . [ 134 ] 
 In another study, Davis et al. designed a 
peptide nanofi ber organization through a 
“biotin sandwich” method for the specifi c 
and controlled delivery of IGF-1 (insulin-
like growth factor) into local myocardia 
microenvironment. IGF-1 bound nano-
fi bers increased the cardiac specifi c marker 
expressions and protein synthesis in vitro. 
Moreover, IGF-1 bound peptide nanofi bers 
reduced cardiomyocyte apoptosis, increased 
their survival and ameliorated the cell therapy 
in vivo after injury. [ 135 ] Hsieh et al. showed 
the advantageous effect of usage of the self-
assembled peptide nanofi bers in myocardial 
protection through prolonged delivery of 
PDGF–BB when co-cultured with endothelial 
cells in vitro, and observed systolic function maintenance after 
myocardia infraction in vivo. [ 136 ] Webber et al. developed bioac-
tive peptide amphiphiles containing fi bronectin-derived RGDS 
sequence, which is an important bioactive epitope for adhe-
sion of bone marrow stromal cells and progenitor cells. They 
proposed the potential effect of these supportive nanofi ber 
scaffolds on the ischemic tissue repair. They demonstrated 
increased biological adhesion, viability, and proliferation of 
these cells as well as maturation of endothelial cells in vitro. 
 Figure 17.  Quantifi ed CAM assay results beginning on embryonic day 10 ( t = day 0) and 
extending for 4 d along with representative images from day 3 for treatments of VEGF PA, 
VEGF peptide, mutant PA, and an untreated control. Reproduced with permission. [ 65 ] Copyright 
2011, National Academy of Science.
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Furthermore, they demonstrated the advanced effect of the 
RGDS nanofi bers as supportive matrix for bone-marrow mono-
nuclear cells in vivo . [ 72 ] 
 Another type of peptide nanofi ber used in cardiovascular 
tissue repair is the heparin-binding peptide amphiphile. HBPA 
is a favorable PA system in myocardial regeneration, as it mimics 
the structure of natural heparin binding proteins and therefore 
increases the cellular recognition of heparin in the ECM. Webber 
et al. reported that paracrine factor delivered with HBPA had a 
nourishing effect on infracted myocardia in vivo . [ 137 ] 
 Metal-based stents are conventionally used for treatment 
of arterial diseases, and we have previously functionalized a 
stainless steel surface with peptide amphiphiles inspired by 
fi bronectin (REDV-PA) and mussel foot adhesion proteins 
(DOPA-PA) to create stent coatings that mimic the natural 
endothelium ECM. In this study, surfaces functionalized with 
a combination of REDV-PA and DOPA-PA were shown to pro-
mote the selective adhesion of endothelial cells and inhibit the 
growth and differentiation of vascular smooth muscle cells, [ 102 ] 
( Figure  19 ) which are promising results for the future clinical 
use of bioactive coatings in cardiovascular stents. 
 4.  Conclusions and Future Perspectives 
 Self-assembling peptide molecules are versatile tools for gen-
eration of biomimetic materials with properties similar to 
that of the native tissue environment. In the repertoire of bio-
medical strategies, nearly all tissues are under exploration for 
regeneration with the help of these peptide scaffolds. In this 
Review, we focused on the published works investigating the 
effects of supramolecular peptide systems on the regenera-
tion of specifi c tissue types. The use of peptide nanofi ber sys-
tems increases with the promising results of different research 
groups. Despite the recent advances and developments, many 
challenges yet remain to be solved. One of these major chal-
lenges is the diffi culty in understanding the mechanisms 
underlying cell response. Enhanced knowledge on these mech-
anisms and complex signaling pathways will enable generation 
of more defi ned synthetic platforms to improve the currently 
used biomaterials. Controlling the compositional aspects of the 
natural microenvironment and regulating the timing of cellular 
processes through these scaffolds are crucial; however, there 
are still many unknown proteins and factors modulating the 
time and amplitude of the changes occurring in the cells. In 
this respect, developments in proteomics can ease the under-
standing of functional domains of these tissue-specifi c pro-
teins and factors. It may improve the strategies to generate 
more advanced peptide scaffolds with new sequences and 
conformations. Through these improvements in the peptide 
design, the complex hierarchical structures of tissues in organ-
ized 3D matrices can be mimicked, so that cells can receive 
all the necessary signals as if they were coming from a native 
matrix. It is also important to precisely control and manipulate 
the responses of the peptide systems upon 
environmental stimuli including chemical, 
mechanical, magnetic and electrical signals 
in order to fabricate stimuli-responsive and 
tissue-specifi c scaffolds. To accomplish these 
controls, employing new characterization 
methods including TEM, AFM, spectroscopy, 
and so forth, and computational approaches 
are required. Furthermore, accurate simu-
lations as well as visualization of the mate-
rials both in vitro and in vivo are essential. 
Advances in the modeling programs for the 
precise simulations of peptide systems can 
provide visualization of the synthetically 
designed network at the molecular and struc-
tural levels. Indeed, this can overcome one 
of the most challenging problems of mim-
icking complex organization of tissues. For 
 Figure 18.  A) Chemical structure of heparin-mimetic PA. B) SEM image of nanofi brous network. C) 1 wt% Heparin–mimetic PA gel injected with 10 ng 
of VEGF- and bFGF-induced vascularization in cornea. D) Application of growth factor solution without PA gel. E) Ratio of vascularized area to total 
area. Reproduced with permission. [ 89 ] Copyright 2011, American Chemical Society.
 Figure 19.  Viability and proliferation of HUVEC and A7r5 smooth muscle cells on stainless 
steel surfaces coated with REDV-PA/Dopa-PA, E-PA/Dopa-PA, and on bare steel surface. Repro-
duced with permission. [ 102 ] Copyright 2011, Elsevier.
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example, extrapolating the responses of peptide nanofi bers and 
the responses of cells (changes in signaling pathways resulting 
in regulation of cell growth, proliferation, differentiation, and 
migration towards desired locations) upon interaction with 
growth factors, cell receptors, enzymes, and other macromol-
ecules can be achieved. Simulation and visualization of these 
systems can also puzzle out the problems associated with the 
unavailability of the bioactive sites on the scaffolds due to 
steric hindrance and unspecifi c interactions. As a result, supe-
rior design of biomaterials with enhanced bioactivity can be 
achieved. 
 Overall, the integration of advanced characterization, simu-
lation, and visualization methods with the genomic and prot-
eomic studies can overcome the current limitations in this 
fi eld. Accordingly, spatiotemporal dynamic microenvironments 
with more sophisticated, advanced and more manageable pep-
tide scaffolds can be constructed. In addition, optimization in 
the design and synthesis of peptides and their conjugates can 
accelerate the production of large-scale and ready-to-use bioma-
terials. Custom-made design of these biomaterials can further 
improve the clinical uses and the fabrication of patient-specifi c 
tissue constructs. Hence, challenges of this highly active fi eld 
of research, at the same time provides opportunities for future 
progress and development of effi cient biomaterials in terms of 
successful repair and regeneration of the damaged tissues. 
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